Founded in 2008 in Ahmedabad, India, Aegis Lifesciences is a globally recognized manufacturer and exporter of advanced hemostatic technologies and wound management solutions. We develop innovative, science-driven products that support bleeding control, tissue care, wound healing, and infection management across clinical, institutional, veterinary, dental, and consumer healthcare applications.

Our diversified portfolio includes Absorbable Gelatin Sponges & Powders (SURGISPON®), Oxidized Regenerated Cellulose (Surgi-ORC®), Medical-Grade PVA Sponges (SURGI-PVA™), Flowable Hemostatic Matrices (FLOGEL®), and a growing range of advanced wound care and specialty healthcare products designed to meet evolving global healthcare needs.

Powered by a state-of-the-art, US FDA-registered manufacturing facility, our operations adhere to the highest international standards of quality, safety, and regulatory compliance. We are proud to hold globally recognized certifications, including CE (Class III Medical Devices), ISO 13485, and MDSAP from M/s DNV and BSI, alongside comprehensive GMP compliances of various countries.

Today, Aegis Lifesciences is delivering trusted healthcare solutions in 100+ countries, including highly regulated markets across Europe, the United States, the United Kingdom (NHS), Russia and Middle East. Through continuous innovation, robust manufacturing capabilities, and a commitment to global quality standards, we remain dedicated to improving patient outcomes and advancing healthcare worldwide.